NASDAQ : EAC

Edify Acquisition Corp.

$10.65 USD

$0.01 (0.09%)

Volume
46.7K
Average Volume
11.1K
Market Capitalization
$84.03M
P/E Ratio
33.28
Dividend Yield
0.00%
Price Target
Year High
$11.40
Year Low
$10.23
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.13
Company Overview

NASDAQ

Ronald H. Schlosser

Shell Companies

Financial Services

EAC

N/A

US

USD

212 603 2800

28059Q103

0001832765

Liquidity Metrics

0.00

0.13

0.13

0.07

0.00

Sales & Valuation

-$

0.00

40.78

-55.84

-0.04

Profitability

$0.32

$11.12M

0.00%

0.00%

8.50%

54.82%

P/E Metrics

33.28

-0.30

-0.30

Analyst Price Target & Rating

N/A

0/5

5 Analysts

%

Financial Health Scores

4.23

3/9

-$3.84M

$11.06M

$8.02M

-$2.22M

Key Metrics (TTM)

$83.97M

0.00

-71.22

0.13

8.50%

-5.74%

3.03%

-1.79%

$1.38

0 days

Company Executives
Name Title
Morris David Beyda Chief Financial Officer
Ronald H. Schlosser Chief Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About Edify Acquisition Corp. (NASDAQ:EAC) Stock

Edify Acquisition Corp. operates without any substantial business activities of its own. Its core objective is to achieve a business combination, such as a merger, asset acquisition, stock exchange, share purchase, or corporate reorganization, with one or more other entities. The company was founded in 2020 and is based in New York, New York. ...

Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers

2026-07-27 08:00:00

Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) demonstrated a statistically significan

Newmont's Red Chris Block Cave Project Receives Major Regulatory Approvals

2026-06-19 13:00:00

Newmont Corporation (NYSE: NEM, ASX: NEM, PNGX: NEM) (“Newmont”) welcomes the Province of British Columbia's approval of key regulatory authorizations for

KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema

2026-05-28 08:00:00

[url="]KalVista Pharmaceuticals[/url], Inc. (Nasdaq: KALV) today announced new data highlighting the burden of injectable on-demand treatment in children aged

Frequently Asked Questions

What is the current Edify Acquisition Corp. (EAC) stock price?

Edify Acquisition Corp.(NASDAQ:EAC) stock price is $10.65 in the last trading session. During the trading session, EAC stock reached the peak price of $11.4 while $10.23 was the lowest point it dropped to. The percentage change in EAC stock occurred in the recent session was 0.09% while the dollar amount for the price change in EAC stock was $0.01.

EAC's industry and sector of operation?

The NASDAQ listed EAC is part of Shell Companies industry that operates in the broader Financial Services sector.

Who are the executives of EAC?

Morris David Beyda | Chief Financial Officer
Ronald H. Schlosser | Chief Executive Officer
|
|
|

How many employees does EAC have?

Number of EAC employees currently stands at None. EAC operates from 888 7th Avenue, New York City, NY 10106, US.

Link for EAC official website?

Official Website of EAC is: https://www.edifyacq.com

How do I contact EAC?

EAC could be contacted at phone #212 603 2800 and can also be accessed through its website. EAC operates from 888 7th Avenue, New York City, NY 10106, US.

How many shares of EAC are traded daily?

The average number of EAC shares traded daily for last 3 months was 11.1K.

What is the market cap of EAC currently?

The market value of EAC currently stands at $84.03M with its latest stock price at $10.65